ArticleChemical biology & drug design2015

Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.

Shanthi Kanthala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.